Structure

Physi-Chem Properties

Molecular Weight:  510.12
Volume:  483.161
LogP:  2.44
LogD:  1.502
LogS:  -4.536
# Rotatable Bonds:  4
TPSA:  180.05
# H-Bond Aceptor:  11
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.263
Synthetic Accessibility Score:  4.038
Fsp3:  0.269
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  2

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.237
MDCK Permeability:  9.425474672752898e-06
Pgp-inhibitor:  0.163
Pgp-substrate:  0.024
Human Intestinal Absorption (HIA):  0.674
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.987

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.067
Plasma Protein Binding (PPB):  93.1323013305664%
Volume Distribution (VD):  0.5
Pgp-substrate:  3.7564809322357178%

ADMET: Metabolism

CYP1A2-inhibitor:  0.083
CYP1A2-substrate:  0.098
CYP2C19-inhibitor:  0.053
CYP2C19-substrate:  0.058
CYP2C9-inhibitor:  0.159
CYP2C9-substrate:  0.158
CYP2D6-inhibitor:  0.04
CYP2D6-substrate:  0.139
CYP3A4-inhibitor:  0.041
CYP3A4-substrate:  0.029

ADMET: Excretion

Clearance (CL):  1.189
Half-life (T1/2):  0.28

ADMET: Toxicity

hERG Blockers:  0.036
Human Hepatotoxicity (H-HT):  0.126
Drug-inuced Liver Injury (DILI):  0.983
AMES Toxicity:  0.884
Rat Oral Acute Toxicity:  0.046
Maximum Recommended Daily Dose:  0.016
Skin Sensitization:  0.057
Carcinogencity:  0.542
Eye Corrosion:  0.003
Eye Irritation:  0.035
Respiratory Toxicity:  0.02

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC205721

Natural Product ID:  NPC205721
Common Name*:   Pseudonocardone C
IUPAC Name:   (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1-hydroxy-8-methoxy-3-methyl-7,12-dioxobenzo[a]anthracen-2-yl)oxyoxane-2-carboxylic acid
Synonyms:   Pseudonocardone C
Standard InCHIKey:  PFYZXYHKMIBQRL-SNYRDRRFSA-N
Standard InCHI:  InChI=1S/C26H22O11/c1-9-8-10-6-7-12-16(18(28)11-4-3-5-13(35-2)15(11)17(12)27)14(10)19(29)23(9)36-26-22(32)20(30)21(31)24(37-26)25(33)34/h3-8,20-22,24,26,29-32H,1-2H3,(H,33,34)/t20-,21-,22+,24-,26+/m0/s1
SMILES:  COc1cccc2c1C(=O)c1ccc3c(c1C2=O)c(O)c(c(c3)C)O[C@@H]1O[C@H](C(=O)O)[C@H]([C@@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2152476
PubChem CID:   71460288
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003415] Angucyclines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32794 pseudonocardia sp. Species Pseudonocardiaceae Bacteria n.a. n.a. n.a. PMID[23025282]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 > 100000.0 nM PMID[459918]
NPT474 Organism Plasmodium berghei Plasmodium berghei IC50 > 100000.0 nM PMID[459918]
NPT1466 Organism Escherichia coli K12 Escherichia coli K-12 MIC > 50.0 ug.mL-1 PMID[459918]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. MIC > 50.0 ug.mL-1 PMID[459918]
NPT20 Organism Candida albicans Candida albicans MIC > 50.0 ug.mL-1 PMID[459918]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MIC > 50.0 ug.mL-1 PMID[459918]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC205721 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9486 High Similarity NPC105591
0.9477 High Similarity NPC47191
0.9474 High Similarity NPC470667
0.9474 High Similarity NPC186800
0.9415 High Similarity NPC199357
0.92 High Similarity NPC277710
0.92 High Similarity NPC114257
0.92 High Similarity NPC153578
0.92 High Similarity NPC212290
0.92 High Similarity NPC299149
0.9191 High Similarity NPC85368
0.9191 High Similarity NPC203751
0.9186 High Similarity NPC52598
0.9162 High Similarity NPC314672
0.9111 High Similarity NPC264302
0.9086 High Similarity NPC289876
0.9086 High Similarity NPC102053
0.907 High Similarity NPC469521
0.9064 High Similarity NPC178281
0.9045 High Similarity NPC231254
0.904 High Similarity NPC475161
0.904 High Similarity NPC477860
0.9034 High Similarity NPC35167
0.9034 High Similarity NPC217520
0.9034 High Similarity NPC139571
0.9029 High Similarity NPC193377
0.9029 High Similarity NPC146803
0.9029 High Similarity NPC68381
0.8994 High Similarity NPC87583
0.8989 High Similarity NPC476203
0.8989 High Similarity NPC36138
0.8983 High Similarity NPC58538
0.8977 High Similarity NPC475246
0.8977 High Similarity NPC144097
0.8977 High Similarity NPC61904
0.896 High Similarity NPC298847
0.895 High Similarity NPC201814
0.8947 High Similarity NPC146837
0.8947 High Similarity NPC278329
0.8947 High Similarity NPC101116
0.8947 High Similarity NPC212099
0.8944 High Similarity NPC65489
0.8939 High Similarity NPC470416
0.8933 High Similarity NPC197357
0.8933 High Similarity NPC85316
0.8933 High Similarity NPC315221
0.8927 High Similarity NPC267680
0.8927 High Similarity NPC217387
0.8927 High Similarity NPC477895
0.8927 High Similarity NPC253521
0.8927 High Similarity NPC293626
0.8927 High Similarity NPC37668
0.8927 High Similarity NPC196127
0.8927 High Similarity NPC267549
0.8927 High Similarity NPC258044
0.8927 High Similarity NPC113836
0.892 High Similarity NPC223426
0.892 High Similarity NPC34267
0.892 High Similarity NPC214621
0.892 High Similarity NPC81042
0.892 High Similarity NPC3718
0.8914 High Similarity NPC111536
0.8914 High Similarity NPC271385
0.8914 High Similarity NPC30432
0.8914 High Similarity NPC76128
0.8914 High Similarity NPC5029
0.8907 High Similarity NPC314020
0.8889 High Similarity NPC111490
0.8889 High Similarity NPC474093
0.8889 High Similarity NPC104910
0.8889 High Similarity NPC261623
0.8883 High Similarity NPC313452
0.8883 High Similarity NPC97119
0.8883 High Similarity NPC135831
0.8883 High Similarity NPC297503
0.887 High Similarity NPC46958
0.887 High Similarity NPC67629
0.887 High Similarity NPC79736
0.8864 High Similarity NPC175230
0.8864 High Similarity NPC4390
0.8864 High Similarity NPC88560
0.8864 High Similarity NPC316539
0.8864 High Similarity NPC172033
0.8864 High Similarity NPC472993
0.8857 High Similarity NPC298778
0.8857 High Similarity NPC204937
0.8857 High Similarity NPC149011
0.884 High Similarity NPC475179
0.884 High Similarity NPC174486
0.8837 High Similarity NPC187934
0.8837 High Similarity NPC469472
0.8837 High Similarity NPC97637
0.8833 High Similarity NPC470713
0.8833 High Similarity NPC25946
0.8833 High Similarity NPC470720
0.8833 High Similarity NPC292706
0.8833 High Similarity NPC460984
0.8833 High Similarity NPC21359
0.8833 High Similarity NPC224557
0.8833 High Similarity NPC470717
0.8827 High Similarity NPC208797
0.8827 High Similarity NPC53680
0.882 High Similarity NPC476620
0.882 High Similarity NPC168584
0.882 High Similarity NPC472387
0.882 High Similarity NPC476621
0.882 High Similarity NPC476622
0.882 High Similarity NPC476618
0.882 High Similarity NPC476623
0.882 High Similarity NPC476619
0.8814 High Similarity NPC294629
0.8814 High Similarity NPC473630
0.8814 High Similarity NPC108202
0.8811 High Similarity NPC3474
0.8807 High Similarity NPC153755
0.8807 High Similarity NPC294501
0.8807 High Similarity NPC292712
0.8807 High Similarity NPC471921
0.8807 High Similarity NPC175107
0.8807 High Similarity NPC114550
0.8807 High Similarity NPC67134
0.8807 High Similarity NPC129930
0.8807 High Similarity NPC474075
0.8807 High Similarity NPC190003
0.8807 High Similarity NPC471920
0.8807 High Similarity NPC47140
0.8807 High Similarity NPC471922
0.8807 High Similarity NPC312006
0.8807 High Similarity NPC20114
0.88 High Similarity NPC222455
0.8791 High Similarity NPC473618
0.8791 High Similarity NPC119094
0.8791 High Similarity NPC173872
0.8786 High Similarity NPC147596
0.8785 High Similarity NPC295625
0.8785 High Similarity NPC473554
0.8785 High Similarity NPC470719
0.8785 High Similarity NPC241847
0.8785 High Similarity NPC469650
0.8778 High Similarity NPC241781
0.8778 High Similarity NPC470718
0.8778 High Similarity NPC473631
0.8778 High Similarity NPC156785
0.8778 High Similarity NPC162394
0.8778 High Similarity NPC475662
0.8778 High Similarity NPC293227
0.8778 High Similarity NPC473717
0.8771 High Similarity NPC471030
0.8771 High Similarity NPC244903
0.8771 High Similarity NPC80956
0.8764 High Similarity NPC472385
0.8764 High Similarity NPC472991
0.8764 High Similarity NPC198324
0.8764 High Similarity NPC472384
0.8764 High Similarity NPC66820
0.8764 High Similarity NPC472723
0.8764 High Similarity NPC472992
0.8764 High Similarity NPC472380
0.8764 High Similarity NPC154741
0.8764 High Similarity NPC475054
0.8764 High Similarity NPC170018
0.8764 High Similarity NPC297574
0.8764 High Similarity NPC296018
0.8764 High Similarity NPC472382
0.8764 High Similarity NPC76112
0.8764 High Similarity NPC268533
0.8764 High Similarity NPC475233
0.8764 High Similarity NPC92403
0.8757 High Similarity NPC472054
0.875 High Similarity NPC206123
0.875 High Similarity NPC155763
0.875 High Similarity NPC235260
0.875 High Similarity NPC20505
0.875 High Similarity NPC116864
0.875 High Similarity NPC244776
0.875 High Similarity NPC478021
0.8743 High Similarity NPC31208
0.8743 High Similarity NPC93065
0.8743 High Similarity NPC469652
0.8743 High Similarity NPC472720
0.8743 High Similarity NPC63470
0.8743 High Similarity NPC116745
0.8743 High Similarity NPC160543
0.8743 High Similarity NPC472721
0.8743 High Similarity NPC472724
0.8736 High Similarity NPC30011
0.8736 High Similarity NPC179947
0.8736 High Similarity NPC260521
0.8736 High Similarity NPC64755
0.8736 High Similarity NPC478020
0.8736 High Similarity NPC72554
0.8736 High Similarity NPC478022
0.8736 High Similarity NPC97817
0.8736 High Similarity NPC469649
0.8729 High Similarity NPC223860
0.8729 High Similarity NPC249560
0.8729 High Similarity NPC275977
0.8729 High Similarity NPC148710
0.8728 High Similarity NPC61594
0.8728 High Similarity NPC56735

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC205721 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8944 High Similarity NPD7879 Clinical (unspecified phase)
0.8833 High Similarity NPD8397 Clinical (unspecified phase)
0.8764 High Similarity NPD8313 Approved
0.8764 High Similarity NPD8312 Approved
0.8708 High Similarity NPD4338 Clinical (unspecified phase)
0.8596 High Similarity NPD6797 Phase 2
0.8547 High Similarity NPD7251 Discontinued
0.8539 High Similarity NPD7074 Phase 3
0.8523 High Similarity NPD6168 Clinical (unspecified phase)
0.8523 High Similarity NPD6166 Phase 2
0.8523 High Similarity NPD6167 Clinical (unspecified phase)
0.8514 High Similarity NPD6232 Discontinued
0.85 High Similarity NPD7808 Phase 3
0.8483 Intermediate Similarity NPD7054 Approved
0.8483 Intermediate Similarity NPD5844 Phase 1
0.8475 Intermediate Similarity NPD7473 Discontinued
0.8474 Intermediate Similarity NPD7435 Discontinued
0.8436 Intermediate Similarity NPD7472 Approved
0.8427 Intermediate Similarity NPD3818 Discontinued
0.838 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8343 Intermediate Similarity NPD6559 Discontinued
0.8316 Intermediate Similarity NPD6781 Approved
0.8316 Intermediate Similarity NPD6777 Approved
0.8316 Intermediate Similarity NPD6778 Approved
0.8316 Intermediate Similarity NPD6782 Approved
0.8316 Intermediate Similarity NPD6779 Approved
0.8316 Intermediate Similarity NPD6776 Approved
0.8316 Intermediate Similarity NPD6780 Approved
0.8287 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8256 Intermediate Similarity NPD8151 Discontinued
0.8249 Intermediate Similarity NPD6959 Discontinued
0.8229 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD7874 Approved
0.8182 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD7075 Discontinued
0.8162 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD7870 Phase 2
0.8144 Intermediate Similarity NPD7871 Phase 2
0.8122 Intermediate Similarity NPD3751 Discontinued
0.8114 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8093 Intermediate Similarity NPD7698 Approved
0.8093 Intermediate Similarity NPD7696 Phase 3
0.8093 Intermediate Similarity NPD7697 Approved
0.8068 Intermediate Similarity NPD3817 Phase 2
0.8057 Intermediate Similarity NPD1934 Approved
0.8053 Intermediate Similarity NPD6534 Approved
0.8053 Intermediate Similarity NPD6535 Approved
0.8051 Intermediate Similarity NPD8319 Approved
0.8051 Intermediate Similarity NPD8320 Phase 1
0.8023 Intermediate Similarity NPD3882 Suspended
0.8022 Intermediate Similarity NPD7228 Approved
0.802 Intermediate Similarity NPD7701 Phase 2
0.8011 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD8455 Phase 2
0.8 Intermediate Similarity NPD3787 Discontinued
0.799 Intermediate Similarity NPD7783 Phase 2
0.799 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD3226 Approved
0.7955 Intermediate Similarity NPD6801 Discontinued
0.7927 Intermediate Similarity NPD7700 Phase 2
0.7927 Intermediate Similarity NPD7699 Phase 2
0.7926 Intermediate Similarity NPD8150 Discontinued
0.7912 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.791 Intermediate Similarity NPD1465 Phase 2
0.791 Intermediate Similarity NPD7819 Suspended
0.7902 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.79 Intermediate Similarity NPD7801 Approved
0.7857 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD7685 Pre-registration
0.7841 Intermediate Similarity NPD4380 Phase 2
0.7833 Intermediate Similarity NPD6234 Discontinued
0.7809 Intermediate Similarity NPD2801 Approved
0.7797 Intermediate Similarity NPD7411 Suspended
0.779 Intermediate Similarity NPD5494 Approved
0.7784 Intermediate Similarity NPD7458 Discontinued
0.7766 Intermediate Similarity NPD6823 Phase 2
0.7765 Intermediate Similarity NPD5402 Approved
0.7753 Intermediate Similarity NPD37 Approved
0.7747 Intermediate Similarity NPD7199 Phase 2
0.774 Intermediate Similarity NPD6599 Discontinued
0.7722 Intermediate Similarity NPD4965 Approved
0.7722 Intermediate Similarity NPD4967 Phase 2
0.7722 Intermediate Similarity NPD4966 Approved
0.772 Intermediate Similarity NPD6212 Phase 3
0.772 Intermediate Similarity NPD6213 Phase 3
0.772 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD2346 Discontinued
0.7657 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7656 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD4628 Phase 3
0.7624 Intermediate Similarity NPD7768 Phase 2
0.7614 Intermediate Similarity NPD1512 Approved
0.76 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD6799 Approved
0.7586 Intermediate Similarity NPD6190 Approved
0.7582 Intermediate Similarity NPD3749 Approved
0.7572 Intermediate Similarity NPD6674 Discontinued
0.7572 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD5403 Approved
0.7566 Intermediate Similarity NPD7240 Approved
0.7557 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7552 Intermediate Similarity NPD8434 Phase 2
0.7541 Intermediate Similarity NPD919 Approved
0.75 Intermediate Similarity NPD1511 Approved
0.7475 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD3926 Phase 2
0.7458 Intermediate Similarity NPD2533 Approved
0.7458 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD2534 Approved
0.7458 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD5401 Approved
0.7458 Intermediate Similarity NPD2532 Approved
0.7457 Intermediate Similarity NPD7266 Discontinued
0.743 Intermediate Similarity NPD1653 Approved
0.7429 Intermediate Similarity NPD7003 Approved
0.7401 Intermediate Similarity NPD7390 Discontinued
0.7399 Intermediate Similarity NPD5405 Approved
0.7399 Intermediate Similarity NPD5408 Approved
0.7399 Intermediate Similarity NPD5406 Approved
0.7399 Intermediate Similarity NPD5404 Approved
0.7366 Intermediate Similarity NPD8127 Discontinued
0.7366 Intermediate Similarity NPD1247 Approved
0.7354 Intermediate Similarity NPD7177 Discontinued
0.7337 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD1549 Phase 2
0.7299 Intermediate Similarity NPD2935 Discontinued
0.7291 Intermediate Similarity NPD7680 Approved
0.7267 Intermediate Similarity NPD1933 Approved
0.7264 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD2799 Discontinued
0.7232 Intermediate Similarity NPD3750 Approved
0.7222 Intermediate Similarity NPD8059 Phase 3
0.7222 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6273 Approved
0.7209 Intermediate Similarity NPD4060 Phase 1
0.7193 Intermediate Similarity NPD6798 Discontinued
0.7178 Intermediate Similarity NPD8285 Discontinued
0.7168 Intermediate Similarity NPD447 Suspended
0.7159 Intermediate Similarity NPD2344 Approved
0.7143 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD8166 Discontinued
0.7119 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD7930 Approved
0.7102 Intermediate Similarity NPD2796 Approved
0.7101 Intermediate Similarity NPD7584 Approved
0.7093 Intermediate Similarity NPD2313 Discontinued
0.7086 Intermediate Similarity NPD7097 Phase 1
0.7083 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD7799 Discontinued
0.7062 Intermediate Similarity NPD5953 Discontinued
0.7053 Intermediate Similarity NPD5710 Approved
0.7053 Intermediate Similarity NPD5711 Approved
0.7052 Intermediate Similarity NPD6233 Phase 2
0.7045 Intermediate Similarity NPD1510 Phase 2
0.7029 Intermediate Similarity NPD1607 Approved
0.7026 Intermediate Similarity NPD7039 Approved
0.7026 Intermediate Similarity NPD7038 Approved
0.7024 Intermediate Similarity NPD2494 Approved
0.7024 Intermediate Similarity NPD2493 Approved
0.7006 Intermediate Similarity NPD1551 Phase 2
0.7 Intermediate Similarity NPD2309 Approved
0.6995 Remote Similarity NPD920 Approved
0.6991 Remote Similarity NPD7907 Approved
0.6984 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6971 Remote Similarity NPD230 Phase 1
0.6971 Remote Similarity NPD7999 Approved
0.6971 Remote Similarity NPD6355 Discontinued
0.6966 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6966 Remote Similarity NPD1471 Phase 3
0.6963 Remote Similarity NPD7229 Phase 3
0.6949 Remote Similarity NPD651 Clinical (unspecified phase)
0.6949 Remote Similarity NPD3748 Approved
0.6942 Remote Similarity NPD3450 Approved
0.6942 Remote Similarity NPD3452 Approved
0.6923 Remote Similarity NPD4582 Approved
0.6923 Remote Similarity NPD4583 Approved
0.6919 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6915 Remote Similarity NPD2488 Approved
0.6915 Remote Similarity NPD2490 Approved
0.6914 Remote Similarity NPD1613 Approved
0.6914 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6914 Remote Similarity NPD1240 Approved
0.6914 Remote Similarity NPD943 Approved
0.6912 Remote Similarity NPD8366 Approved
0.691 Remote Similarity NPD2438 Suspended
0.6908 Remote Similarity NPD3057 Approved
0.6905 Remote Similarity NPD7585 Approved
0.6901 Remote Similarity NPD1470 Approved
0.6898 Remote Similarity NPD4665 Approved
0.6898 Remote Similarity NPD4111 Phase 1
0.6897 Remote Similarity NPD3764 Approved
0.6889 Remote Similarity NPD5698 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data